Key facts
- Wespran’s last known valuation is $1.8M (Dec 2024).
- It has raised $420K; the latest was Early Stage VC ($420K) in Dec 2024.
- Notable investors include General Inception.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Wespran
- ·The full record, as it builds
Funding rounds
No funding rounds for Wespran are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Wespran
Operator of a bioinformatics and machine learning company intended to to solve greenhouse gas emission problems. The company develops sustainable bioprocesses with industrial applications in synthetic biology such as the biological degradation of plastics or the cell-free production of chemical compounds, enabling industries to reduce their carbon footprint while generating substantial profit.
- Sector
- Healthcare
- HQ
- Lyon, France
- Founded
- 2022
- Employees
- 2
- Website
- wespran.com/
- Ownership
- Privately Held (backing)
Wespran doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Wespran shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Wespran in its N-PORT filings yet. We sweep new filings monthly.